Gammagard, an intravenous immune therapy drug, is being hailed in the media as a solution for stabilizing Alzheimer's disease after early stages of testing. Take a look 'Behind the Headlines' to find out why it's far too early to know the message. http://1.usa.gov/rSGxQO
Photo
Shared publiclyView activity